medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2010, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2010; 8 (2)

Acute pustular eruption due to emergence contraception (postcoital)

Poletti E, Guzmán PG, Muñoz FL

Language: Spanish
References: 42
Page: 141-146
PDF size: 236.04 Kb.


ABSTRACT

We present the case of an acute exanthematous pustulosis reaction, sterile, pruriginous, generalized, febrile, with leukocytosis and increase in acute-phase reactants, in a 32 year old woman. Her only background of importance was the administration of levonorgestrel for emergency contraception. Diagnosis was corroborated by histopathology. She had a quick and satisfactory evolution allowing the integral confirmation of this disease. This entity is also caused by other pharmacologic modalities of contraception. This case also reinforces the importance of communicating the medical community the adverse reactions shown by new drugs at the slightest suspicion.


REFERENCES

  1. Callen JP, Jorizzo JL, Bolognia JL, Piette WW, Zone JJ. Dermatological signs of internal disease. 4a ed. Filadelfia, Saunders Elsevier, 2009, 401- 410.

  2. Roujeau JC, Bioulac-Sage P, Bourseau C et al. “Acute generalized exanthematous pustulosis: Analysis of 63 cases”. Arch Dermatol 1991; 127: 1333-1338.

  3. Sidoroff A, Dunant A, Viboud C et al. “Risk factors for acute generalized exanthematous pustulosis (AGEP) —results of a multinational casecontrol study (EuroSCAR)”. Br J Dermatol 2007; 157: 989-996.

  4. Sidoroff A, Halevy S, Bavinck JN et al. “Acute generalized exanthematous pustulosis (AGEP) —a clinical reaction pattern”. J Cutan Pathol 2001; 28: 113-119.

  5. Beylot C, Bioulac P, Doutre MS. “Acute generalized exanthematic pustuloses (four cases)”. Ann Dermatol Venereol 1980; 107: 37-48.

  6. Bernard P, Lizeaux-Parneix V, Miossec V et al. “HLA et prédisposition génétique dans les pustuloses exanthématiques (PEAG) et les exanthémes maculapapuleux (EMP)”. Ann Dermatol Venereol 1995; 122: S38-S39.

  7. Baker H, Ryan TJ. “Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases”. Br J Dermatol 1968; 80: 771-793.

  8. Chang SL, Huang YH, Yang CH et al. “Clinical manifestations and characteristics of patients with acute generalized exanthematous pustulosis in Asia”. Acta Derm Venereol 2008; 88: 363-365.

  9. Ersoy S, Paller AS, Mancini AJ. “Acute generalized exanthematous pustulosis in children”. Arch Dermatol 2004; 140: 1172-1173.

  10. Soto-Ortiz JA, Guzmán-Sánchez DA. “Pustulosis generalizada de inicio súbito”. Piel 2006; 21(3): 151-153.

  11. Sulewski RJ Jr, Blyumin M, Kerdel A. “Acute generalized exanthematous pustulosis due to clindamycin”. Dermatol Online J 2008; 14: 1-8.

  12. Kapoor R, Flynn C, Heald PW et al. “Acute generalized exanthematous pustulosis induced by clindamycin”. Arch Dermatol 2006; 142: 1080- 1081.

  13. Grieco T, Cantisani C, Innocenzi D et al. “Acute generalized exanthematous pustulosis caused by piperacillin/tazobactam”. J Am Acad Dermatol 2005; 52: 732-733.

  14. Guevara-Gutierrez E, Uribe-Jimenez E, Diaz-Canchola M, Tlacuilo- Parra A. “Acute generalized exanthematous pustulosis: Report of 12 cases and literature review”. International Journal of Dermatology 2009; 48: 253-258.

  15. Heinemann C, Wiesend CL, Hipler C et al. “Acute generalized exanthematous pustulosis (AGEP) after oral use of amphotericin B”. J Am Acad Dermatol 2007; 57(supl. 2): S61-S63.

  16. Paradisi A, Bugatti L, Sisto T et al. “Acute generalized exanthematous pustulosis induced by hydroxychloroquine: Three cases and a review of the literature, case series”. Clin Ther 2008; 30: 930-940.

  17. Elston GE, Johnston GA, Mortimer NJ et al. “Acute generalized exanthematous pustulosis associated with azathioprine hypersensitivity”. Clin Exp Dermatol 2006; 32: 52-53.

  18. Martins A, Lopes LC, Paiva-Lopes MJ et al. “Acute generalized exanthematous pustulosis induced by hydroxychloroquine”. Eur J Dermatol 2006; 16: 317-318.

  19. Teixeira M, Silva E, Selores M. “Acute generalized exanthematous pustulosis induced by nimesulide”. Dermatol Online J 2006; 12: 20.

  20. Bar M, John L, Wonschik S et al. “Acute generalized exanthematous pustulosis induced by high-dose prednisolone in a young woman with optic neuritis owing to disseminated encephalomyelitis”. Br J Dermatol 2008; 159: 251-252.

  21. Huang YM, Lee WR, Hu CH et al. “Propafenone induced acute generalized exanthematous pustulosis”. Int J Dermatol 2005; 44: 256-257.

  22. Komericki P, Grims R, Kränke B et al. “Acute generalized exanthematous pustulosis from dalteparin”. J Am Acad Dermatol 2007; 57: 718-721.

  23. Patrizi A, Tabanelli M, Antonucci A et al. “Acute generalized exanthematous pustulosis induced by pentoxifylline”. Int J Dermatol 2007; 46: 1310-1311.

  24. Valks R, Fraga J, Muñoz E et al. “Acute generalized exanthematous pustulosis in patients receiving high-dose chemotherapy”. Arch Dermatol 1999; 135: 1418-1420.

  25. Sugita K, Nishio D, Kabashima K et al. “Acute generalized exanthematous pustulosis caused by sennoside in a patient with multiple myeloma”. J Eur Acad Dermatol Venereol 2008; 22: 517-519.

  26. Tsai YS, Tu ME, Wu YH et al. “Hydroxyzine-induced acute generalized exanthematous pustulosis”. Br J Dermatol 2007; 157: 1296-1297.

  27. Coe JW, Brooks PR, Vetelino MG et al. “Varenicline: An alpha4beta2 nicotinic receptor partial agonist for smoking cessation”. J Med Chem 2005; 48: 3474-3477.

  28. Oncken C, Gonzales D, Nides M et al. “Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation”. Arch Intern Med 2006; 166: 1571-1577.

  29. Duparc A, Gosset P, Caron J, Lasek A, Modiano P. “Acute generalized exanthematous pustulosis caused by varenicline”. J Eur Acad Dermatol Venereol 2009; 23: 1092-1115.

  30. Litt JZ. Litt´s drug eruption reference manual. 15a ed. Filadelfia, Informa Healthcare, 2009, 590-592.

  31. Davidovici BB, Pavel D, Cagnano E et al. “Acute generalized exanthematous pustulosis following a spider bite: Report of 3 cases”. J Am Acad Dermatol 2006; 55: 525-529.

  32. Lu LK, High WA. “Acute generalized exanthematous pustulosis caused by illicit street drugs?” Arch Dermatol 2007; 143: 430-431.

  33. Kardaun SH, de Monchy JG. “Acute generalized exanthematous pustulosis caused by morphine, confirmed by positive patch test and lymphocyte transformation test”. J Am Acad Dermatol 2006; 55(supl. 2):S21-S23.

  34. Salem BC, Slim R, Denguezli M et al. “Pseudoephedrine induced acute generalized exanthematous pustulosis”. Int J Dermatol 2008; 47: 418- 419.

  35. Lerch M, Bircher AJ. “Systematically induced allergic exanthem from mercury”. Contact Dermatitis 2004; 50: 349-353.

  36. Belhadjali H, Mandhouj S, Moussa A, Njim L, Amri M, Zakhama A , Zili J. “Mercury-induced acute generalized exanthematous pustulosis misdiagnosed as a drug-related case”. Contact Dermatitis 2008; 59: 52-54.

  37. Britschgi M, Steiner UC, Schmid S et al. “T-cell involvement in druginduced acute generalized exanthematous pustulosis”. J Clin Invest 2001; 107: 1433-1441.

  38. Schmid S, Kuechler PC, Britschgi M et al. “Acute generalized exanthematous pustulosis: Role of cytotoxic T cells in pustule formation”. Am J Pathol 2002; 161: 2079-2086.

  39. Lazarov A, Livni E, Halevy S. “Generalized pustular drug eruptions: Confirmation by in vitro tests”. J Eur Acad Dermatol Venereol 1998; 10: 36-41.

  40. Kubba A. “Anticoncepción hormonal postcoital”. Revista Europea de Contracepción y Salud Reproductiva 1997; 2: 101-104.

  41. Glasier A, Baird D. “The effects of self-administering emergency contraception”. N Engl J Med 1998; 339: 1-4.

  42. Trussell J, Duran V, Shochet T, Moore K. “Access to emergency contraception”. Obstet Ginecol 2000; 95: 267-270.




2020     |     www.medigraphic.com